MICHELI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 2.242
AS - Asia 2.023
EU - Europa 1.963
SA - Sud America 189
AF - Africa 89
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.520
Nazione #
US - Stati Uniti d'America 2.159
CN - Cina 571
SG - Singapore 557
IT - Italia 553
DE - Germania 453
GB - Regno Unito 315
HK - Hong Kong 211
BD - Bangladesh 209
VN - Vietnam 167
RU - Federazione Russa 150
BR - Brasile 135
SE - Svezia 99
FR - Francia 97
IN - India 90
ID - Indonesia 78
NL - Olanda 65
CA - Canada 60
FI - Finlandia 53
IE - Irlanda 47
CI - Costa d'Avorio 38
KR - Corea 27
DK - Danimarca 23
TR - Turchia 20
UA - Ucraina 20
AR - Argentina 19
JP - Giappone 19
CH - Svizzera 15
AU - Australia 12
CO - Colombia 12
ZA - Sudafrica 12
BE - Belgio 11
PH - Filippine 10
ES - Italia 9
PL - Polonia 9
AT - Austria 8
MX - Messico 8
RO - Romania 8
SA - Arabia Saudita 8
IQ - Iraq 7
CL - Cile 6
ET - Etiopia 6
MA - Marocco 6
UZ - Uzbekistan 6
BG - Bulgaria 5
EC - Ecuador 5
EG - Egitto 5
IR - Iran 5
UG - Uganda 5
AL - Albania 4
KE - Kenya 4
PE - Perù 4
TW - Taiwan 4
JM - Giamaica 3
KZ - Kazakistan 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
SC - Seychelles 3
TH - Thailandia 3
TJ - Tagikistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
PR - Porto Rico 2
PY - Paraguay 2
TN - Tunisia 2
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MZ - Mozambico 1
NG - Nigeria 1
Totale 6.513
Città #
Frankfurt am Main 364
Ashburn 311
Singapore 302
Southend 263
Hong Kong 187
Milan 180
San Jose 159
Chandler 148
Dallas 115
Fairfield 105
Beijing 89
Los Angeles 80
Santa Clara 75
Council Bluffs 71
New York 70
Seattle 70
The Dalles 67
Wilmington 58
Ho Chi Minh City 55
Hefei 51
Rome 50
Dublin 46
Princeton 43
Jakarta 42
Buffalo 41
Woodbridge 39
Abidjan 38
Cambridge 37
Ann Arbor 36
Helsinki 34
Bengaluru 33
Guangzhou 33
Boardman 32
Houston 30
Hanoi 29
Lauterbourg 29
Phoenix 26
Toronto 25
Moscow 24
Munich 23
Shanghai 23
Redwood City 21
Naples 19
São Paulo 18
Turin 18
Dearborn 17
Nanjing 16
Cangzhou 15
Columbus 15
Seoul 15
Tokyo 15
Nuremberg 14
Margão 13
Da Nang 12
London 12
San Diego 12
Des Moines 11
Istanbul 11
Segrate 11
Atlanta 10
Dong Ket 10
Fuzhou 10
Montreal 10
San Valentino Torio 10
Shenzhen 10
Medellín 9
Mumbai 8
Nanchang 8
Vienna 8
Brooklyn 7
Brussels 7
Changsha 7
Florence 7
Jinan 7
Johannesburg 7
Kent 7
Lappeenranta 7
Ottawa 7
Paris 7
Shenyang 7
Zurich 7
Chicago 6
Hillsboro 6
Hyderabad 6
Jacksonville 6
Piscataway 6
Rio de Janeiro 6
Riyadh 6
St Petersburg 6
Turku 6
Washington 6
Wuhan 6
Addis Ababa 5
Amsterdam 5
Bexley 5
Biên Hòa 5
Boston 5
Bắc Giang 5
Cassano Magnago 5
Central District 5
Totale 4.081
Nome #
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 488
Improvement of ALT decay kinetics by all-oral HCV treatment : role of NS5A inhibitors and differences with IFN-based regimens 358
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 319
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response 277
Favorable therapeutic response with an antiretroviral salvage regimen in an HIV-1-positive subject infected with a CRF11-cpx virus 274
Time and mode of epidemic hcv-2 subtypes spreading in Europe: Phylodynamics in Italy and Albania 258
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 257
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 257
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 251
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy : 48-Week results of a randomized trial 245
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 240
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 235
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 234
Geographical reconstruction of the SARS‐CoV‐2 outbreak in Lombardy (Italy) during the early phase 217
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 192
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 186
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 185
Viral bloodstream detection in mpox patients: An observational multicentric study 185
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 184
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 183
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation 174
Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy 171
A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge? 170
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI 157
A perspective Italian study on HIV-1 resistance in naive patients for antiretroviral therapy 151
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 140
Two individuals with potential monkeypox virus reinfection 128
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies 124
Immunological failure in an HIV élite controller: Possible role of indirect markers of inflammation and benefit of antiretroviral therapy 124
Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient 121
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 110
Evaluation of HIV-1 drug resistance in newly diagnosed individuals in Italy over the period 2017-2023 81
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study 35
null 3
Totale 6.714
Categoria #
all - tutte 20.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022439 29 24 35 10 43 25 34 21 52 58 14 94
2022/2023532 62 63 46 46 32 82 11 37 63 16 45 29
2023/2024716 23 41 34 40 150 54 70 65 28 48 76 87
2024/20251.185 77 115 54 124 83 65 62 93 65 134 112 201
2025/20262.654 255 187 263 237 186 148 391 105 214 173 274 221
2026/2027124 124 0 0 0 0 0 0 0 0 0 0 0
Totale 6.714